Pharmaceutical News and Articles

Brain Functional Networks Affected by Neoadjuvant Chemo in Breast Cancer

For patients with breast cancer, the brain functional network shows a shift toward a more randomized pattern after neoadjuvant chemotherapy (NAC), with progress

Link Between Global β-Amyloid, Tau Deposition Varies by Sex

Women and individuals with a paternal history of Alzheimer disease (AD) have a stronger association between global -amyloid (A ) and tau deposition, according t

Two Deaths in Oregon County Linked to Fatal Brain Disorder

MONDAY, April 14, 2025 Health officials in Hood River County, Oregon, are investigating three cases of a rare and fatal brain disease known as Creutzfeldt-Jakob

Prostate Cancer Screening Program Beneficial in Top Decile of Polygenic Risk Score

A prostate cancer screening program involving participants in the top decile of risk according to a polygenic risk score identifies clinically significant disea

Fisher-Price Recalls 253,000 Baby Toys Over Choking Risk

MONDAY, April 14, 2025 Fisher-Price has recalled 253,000 baby stroller toys in the U.S. because of a choking risk, according to the U.S. Consumer Product Safety

Argenx Announces FDA Approval of Vyvgart Hytrulo Prefilled Syringe for Self-Injection

Verve Therapeutics Receives U.S. FDA Fast Track Designation for VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9

Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that the U.S. Food and Drug

Uplizna (inebilizumab-cdon) is Now the First and Only FDA-Approved Treatment for IgG4-Related Disease

FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) as a Treatment for Patients with Previously Untreated Microsatellite Instability-High or Mismatch Repair Deficient Unresectable or Metastatic Colorectal Cancer

U.S. FDA Grants Full Approval of Vitrakvi (larotrectinib) for Adult and Pediatric Patients with NTRK Gene Fusion-Positive Solid Tumors